Discover 3,591 paid clinical trials in Fullerton, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,591
Active & Responsive
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
for
Smoking Cessation
Location: Pomona CA, Lemon Grove CA, Fort Worth TX, Austin TX,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07766655
Phase 3, Recruiting
Active & ResponsiveNew
Time Comparison of Interventions on Bowel Programs in Spinal Cord Injury
for
Spinal Cord Injury, Neurogenic Bowel
Location: Pomona CA
Sponsor: Casa Colina Hospital and Centers for Healthcare
Sex: All
Age: 18+
Code: NCT07817199
Recruiting
Active & Responsive
Ultrasound Stimulation for Patients in a Disorder of Consciousness
for
Consciousness Disorders,
Location: Pomona CA, Los Angeles CA, Boston MA
Sponsor: University of California, Los Angeles
Sex: All
Age: 18 - 70+
Code: NCT06939348
Recruiting
Active & Responsive
A Phase 1/2 Study of BHV-1510 (Previously PBI-410) in Advanced Solid Tumors
for
Solid Tumor
Location: Duarte CA, La Jolla CA, Palo Alto CA,
Sponsor: Biohaven Therapeutics Ltd.
Sex: All
Age: 18+
Code: NCT06384807
Phase 1, Phase 2, Recruiting
Active & Responsive
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
for
Migraine
Location: Pomona CA, Los Angeles CA, Palm Springs CA, Phoenix AZ,
Sponsor: Mayo Clinic
Sex: All
Age: 18 - 70
Code: NCT06972056
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
for
Overweight, Obesity
Location: Huntington Park CA, Rolling Hills Estates CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07589608
Phase 2, Recruiting
Active & Responsive
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
for
Overweight, Obesity
Location: Huntington Park CA, Los Angeles CA, Escondido CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07770841
Phase 3, Recruiting
Active & Responsive
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
for
Obesity, Overweight
Location: Huntington Park CA, Rolling Hills Estates CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT06143956
Phase 2, Recruiting
Active & Responsive
A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
for
Major Depressive Disorder
Location: Montclair CA, Redlands CA, Oceanside CA, San Jose CA,
Sponsor: Syndeio Biosciences, Inc
Sex: All
Age: 18 - 64
Code: NCT07115329
Phase 2, Recruiting
Active & Responsive
Universal Rare Gene Study: A Registry and Natural History Study of Retinal Dystrophies Associated With Rare Disease-Causing Genetic Variants
Location: Los Angeles CA, San Francisco CA, Salt Lake City UT,
Sponsor: Jaeb Center for Health Research
Sex: All
Age: 4+
Code: NCT05589714
Recruiting
Active & Responsive
Examination of Nociscan Impact on Low Back Pain Surgical Outcomes
for
Low Back Pain
Location: Los Angeles CA, Beverly Hills CA, La Jolla CA,
Sponsor: Aclarion
Sex: All
Age: 18 - 70
Code: NCT06661850
Recruiting
Active & Responsive
Validation of Early Prognostic Data for Recovery Outcome After Stroke for Future, Higher Yield Trials
for
Stroke, Stroke, Acute, Stroke, Ischemic
Location: Los Angeles CA, Redwood City CA, San Francisco CA,
Sponsor: Yale University
Sex: All
Age: 18+
Code: NCT05338697
Recruiting
Active & Responsive
A Study of the Effect of ZT-01 on Night-time Hypoglycemia in Type 1 Diabetes
for
Type 1 Diabetes Mellitus With Hypoglycemia
Location: Los Angeles CA, Escondido CA, Las Vegas NV,
Sponsor: Zucara Therapeutics Inc.
Sex: All
Age: 18 - 70+
Code: NCT05762107
Phase 2, Recruiting
Active & Responsive
Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer